Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$11.31
-2.33%
Mkt Cap $686.33M
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
Implied Upside
+127.8%
Consensus $25.75 vs current $11.31
NASDAQ·Healthcare·Biotechnology
$11.31
-2.33%
Mkt Cap $686.33M
Buy
13
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
+127.8%
Consensus $25.75 vs current $11.31